“…These costs have most often been observed as reductions in fecundity, effectively translating into reproduction-survival trade-offs in the presence of pathogens [ 9 , 10 , 12 , 22 , 30 – 34 ]. In polygamous species, where sexual selection on males is intense, females are often predicted to gain more than males from investing in survival and longevity at the cost of current reproduction and mating effort [ 3 , 9 , 35 ] and are therefore also predicted to invest more in immunity than males (but see: [ 2 , 10 , 24 , 35 – 37 ]). Sexual selection may also have pronounced direct effects on optimal investment in immunity, as it may dictate the economics of reproduction [ 23 , 27 , 38 , 39 ] and lead to elevated mating rates [ 40 ], which in turn may increase disease transmission [ 16 , 24 , 25 , 28 ].…”